Female Sexual Dysfunction in Women After Treatment of Cervical Dysplasia

Litman, Ethan; Cigna, Sarah T

doi:10.1016/j.sxmr.2022.02.003

Cited by 4 publications

(2 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, none of them compared the results with a control group. In fact, a recent review indicates that there is a lack of research on sexual dysfunction in cervical cancer survivors due to study limitations, such as inconsistent comparison groups and lack of use of standardized questionnaires [ 5 ].…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, due to the increased survival of cervical cancer, it is necessary to improve the quality of life of these patients [ 3 , 4 ]. In this vein, sexual satisfaction, in which the cervix plays an important role in orgasm and sexual function, is a fundamental dimension of the human being and is recognized as a good indicator of quality of life [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of Cervical Cancer on Quality of Life and Sexuality in Female Survivors

Membrilla-Beltran

Cardona

Cámara-Roca

et al. 2023

IJERPH

View full text Add to dashboard Cite

Cervical cancer is the fourth most frequent cancer in women worldwide, and the 11th most frequent neoplasm in Spain. Despite the optimization of treatments and a 5-year survival rate of 70%, side effects and sequelae are described after treatment. The treatments have physical, psychological and sociocultural consequences that deteriorate the quality of life of patients. One of the sequelae that worries patients is the impairment of sexual function and satisfaction, considered a fundamental dimension of the human being. The aim of this study was to examine quality of life and sexual function and satisfaction among Spanish cervical cancer survivors. A retrospective case-control study was conducted between 2019 and 2022. The sample consisted of 66 patients who completed the Female Sexual Function Index, the Golombok Rust Sexual Satisfaction Inventory and European Organization for Research and Treatment of Cancer quality of life questionnaire. The control group consisted of women without cervical cancer and gynecological pathologies obtained using the so-called online virtual sampling method. The patient group consisted of women with cervical cancer who completed treatment. Cervical cancer survivors reported sexual dysfunction and impaired sexual satisfaction in almost half of the domains. Quality of life was also affected, with pain and fatigue being the most frequent symptoms in these patients. Our results indicate that there is dysfunction, sexual dissatisfaction and a lower level of quality of life in cervical cancer survivors than in healthy women without pathology.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Impact of Cervical Cancer on Quality of Life and Sexuality in Female Survivors

Membrilla-Beltran

Cardona

Cámara-Roca

et al. 2023

IJERPH

View full text Add to dashboard Cite

show abstract

Sexual Quality of Life and Sexual Problems of Women with Gynecological Cancer: Evaluation According to Treatment Methods and Cancer Types

Delican,

Güngörmüş

2023

Sex Disabil

View full text Add to dashboard Cite

Associations between gynecologic clinician type and routine female sexual dysfunction screening

Berry

Capbarat

Walker

et al. 2023

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Background Female sexual dysfunction (FSD) is a common problem in the United States; however, only 14% to 40% of women are screened by their health care clinicians. There are few data on how differences in clinician type affects screening rates. Aim This study aimed to assess differences in FSD screening rates among gynecology clinician types, identify factors associated with screening, and compare screening rates of FSD against conditions with established screening recommendations. Methods Data were collected by retrospective chart review of annual visits at an urban tertiary care center. Screening rates for FSD, depression, cervical cancer, and breast cancer were calculated and compared. Multivariable logistic regression modeling was utilized to assess the correlation between various patient characteristics and FSD screening rates. Outcomes Study outcome measures included percentages of women who were screened for FSD, depression, cervical cancer, and breast cancer. Results FSD screening rate was significantly higher among resident-level clinicians vs nonresident clinicians (59% vs 31%; P < .001). When the nonresident clinicians were subanalyzed, certified nursing midwives were the second most likely to screen for FSD (odds ratio [OR], 0.41), followed by nurse practitioners (OR, 0.29) and attending physicians (OR, 0.22). According to multivariable logistic regression techniques, 5 factors were associated with an increased likelihood of a patient being screened for FSD at an annual examination: patient seen by a resident physician rather than an attending physician, patient history of FSD, patient age ≥40 years, patient report of being sexually active at the time of visit, and patient history of cervical procedures. Clinical Implications There is an opportunity to improve FSD screening rates by clinicians. Future research may assess what factors, such as increased sexual function education or greater incentives to document FSD screening, may result in higher screening rates. From this, targeted and effective interventions might be crafted to improve future screening rates. Strengths and Limitations This study is one of the first to compare FSD screening rates among clinician types in the same specialty. Study limitations include the inherent limitations of a retrospective design, including selection biases. Conclusion Residents were more likely to screen for FSD at annual well-woman visits than attending clinicians, nurse practitioners, and certified nurse midwives. Understanding the reasons for varied FSD screening rates among clinician types may aid in the development of strategies to improve screening for this important aspect of women’s health.

show abstract

Female Sexual Dysfunction in Women After Treatment of Cervical Dysplasia

Cited by 4 publications

References 46 publications

Impact of Cervical Cancer on Quality of Life and Sexuality in Female Survivors

Impact of Cervical Cancer on Quality of Life and Sexuality in Female Survivors

Sexual Quality of Life and Sexual Problems of Women with Gynecological Cancer: Evaluation According to Treatment Methods and Cancer Types

Associations between gynecologic clinician type and routine female sexual dysfunction screening

Contact Info

Product

Resources

About